Pereria Publishes Article in Journal for Nurse Practitioners

Pereria Publishes Article in Journal for Nurse Practitioners

Katherine Pereria published an article entitled "Biosimilar Glargine Insulin: Implications for Prescribers and Patients" in the "Prescription Pad" section of the March issue of the Journal for Nurse Practitioners.

Abstract: The first biosimilar insulin released in the US will be biosimilar glargine (Basaglar). Biosimilars are “highly similar” to an approved reference medication. Biosimilar glargine is estimated to cost 20% to 40% less than brand name glargine.

Scroll back to top automatically